Alphamab Oncology's total assets for Q4 2024 were ¥2.24B, an increase of 4.66% from the previous quarter. HK:9966 total liabilities were ¥409.87M for the fiscal quarter, a -20.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.